Authors/Disclosures
|
Channa A. Hewamadduma, MBBS, PhD, FRCP, MSc
(Royal Hallamshire Hospital)
|
Dr. Hewamadduma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Hewamadduma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ARENX. Dr. Hewamadduma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIOGEN. Dr. Hewamadduma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROCHE. The institution of Dr. Hewamadduma has received research support from Neurocare . The institution of Dr. Hewamadduma has received research support from Sheffield Charitable Trust. Dr. Hewamadduma has received personal compensation in the range of $5,000-$9,999 for serving as a Adult Expert with National Health Service England (NHSE). |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Pravin Khemani, MD, FÂ鶹´«Ã½Ó³»
(Swedish Neuroscience Institute)
|
Dr. Khemani has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cala Trio. Dr. Khemani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Khemani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Pamela J. Shaw, MD, FRCP, FÂ鶹´«Ã½Ó³»
(The University of Sheffield, Sheffield Inst for Translational Neurosc)
|
No disclosure on file |